Literature DB >> 9242440

Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors.

S Goodison1, K Yoshida, T Sugino, A Woodman, H Gorham, J Bolodeoku, M Kaufmann, D Tarin.   

Abstract

In normal tissues, the steady-state level of CD44 mRNA is low, and the variety of alternatively spliced transcripts produced by this complex gene is limited. Conversely, increased and disorderly expression of this gene has been observed in a number of types of cancer. This study analyzed the order in which the CD44 variant exons are spliced together in gastrointestinal tumor cell lines and in 20 colonic carcinomas and matched normal mucosa. We used a PCR-based assay to analyze specific exon junctions at the boundary of the standard and variant regions of the CD44 gene transcripts. This revealed characteristically different splicing preferences in colonic tumor and normal tissues. The junction of exon 5 to exon 8 appeared to be the most prevalent in normal mucosa, whereas the presence of junctions between exon 5 and either exon 7, 9, or 11 were increased markedly in tumor samples. These observations demonstrate that the unusual variety of CD44 transcripts in cancer cells results from the fidelity of alternative splicing mechanisms being compromised and are potentially useful as tumor cell markers in diagnostic assays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242440

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Expression of CD44v6 gene in normal human peripheral blood.

Authors:  Jian Song; Dong-Sheng Zhang; Jie Zheng
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 2.  CD44 cell adhesion molecules.

Authors:  S Goodison; V Urquidi; D Tarin
Journal:  Mol Pathol       Date:  1999-08

3.  SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression.

Authors:  Libang Yang; Jianbo Yang; Blake Jacobson; Adam Gilbertsen; Karen Smith; LeeAnn Higgins; Candace Guerrero; Hong Xia; Craig A Henke; Jizhen Lin
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

4.  Multiple intron retention occurs in tumor cell CD44 mRNA processing.

Authors:  S Goodison; K Yoshida; M Churchman; D Tarin
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

5.  Up-regulation of CD44 variant exon expression in endometrial carcinomas: analysis of mRNA and protein isoforms, and relation to clinicopathological factors.

Authors:  M Saegusa; I Okayasu
Journal:  Jpn J Cancer Res       Date:  1998-03

6.  Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction.

Authors:  Y Yamada; N Itano; H Narimatsu; T Kudo; S Hirohashi; A Ochiai; A Niimi; M Ueda; K Kimata
Journal:  Jpn J Cancer Res       Date:  1999-09

7.  Thermochemotherapy effect of nanosized As2O3/Fe3O4 complex on experimental mouse tumors and its influence on the expression of CD44v6, VEGF-C and MMP-9.

Authors:  Yiqun Du; Dongsheng Zhang; Hui Liu; Rensheng Lai
Journal:  BMC Biotechnol       Date:  2009-10-05       Impact factor: 2.563

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.